Literature DB >> 10325243

Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo.

S Tomita1, N Tomita, T Yamada, L Zhang, Y Kaneda, R Morishita, T Ogihara, V J Dzau, M Horiuchi.   

Abstract

Renin is synthesized in high quantities in the juxtaglomerular cells of the kidney, but little or none is synthesized in the liver. Our previous in vitro and biochemical studies have demonstrated that tissue-specific expression of the mouse renin gene is regulated by the specific interaction between negative regulatory element (NRE) in the 5'-flanking region of the renin gene and NRE binding protein (NREB). In this study, we examined the hypothesis that this interaction between the NRE in the promoter region of the rat renin gene and the NREB in the liver contributes to the suppressed renin gene expression in this tissue in vivo. We used in vivo transfection of NRE transcription factor decoy (TFD) double-stranded oligonucleotide into the rat liver via portal vein infusion. A gel mobility shift assay showed that transfected NRE TFD blocked endogenous NREB binding with the rat renin gene. This resulted in enhanced hepatic renin mRNA expression, immunohistochemical detection of renin in the liver, and consequently, increased plasma renin concentration. Taken together, these results document the importance of NREB in the inhibition of renin gene expression in rat liver in vivo and suggest the possibility of in vivo renin gene modulation by the TFD approach.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325243     DOI: 10.1161/01.res.84.9.1059

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.

Authors:  K Tamura; Y E Chen; M Horiuchi; Q Chen; L Daviet; Z Yang; M Lopez-Ilasaca; H Mu; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

4.  Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.

Authors:  Chun-Xiao Yu; Tong Jin; Wei-Wen Chen; Peng-Ju Zhang; Wen-Wen Liu; Heng-Yun Guan; Ju Zhang; Qing-Wei Liu; An-Li Jiang
Journal:  Mol Biol Rep       Date:  2009-03-05       Impact factor: 2.316

Review 5.  Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.

Authors:  Naruya Tomita; Naoki Kashihara; Ryuichi Morishita
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

Review 6.  Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.

Authors:  Zainab Mastoor; Yolanda Diz-Chaves; Lucas C González-Matías; Federico Mallo
Journal:  Metabolites       Date:  2022-05-03

Review 7.  Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.

Authors:  David T Denhardt; Devra Mistretta; Ann F Chambers; Shuba Krishna; Joseph F Porter; Srilatha Raghuram; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.